1-4 of 4
Ingrid Marschitz
Close
Sort by
Journal Articles

Interleukin-15 as a potential costimulatory cytokine in CD154 gene therapy of chronic lymphocytic leukemia

Gabriele Anether, Ingrid Marschitz, Inge Tinhofer, Richard Greil
Journal: Blood
Blood (2002) 99 (2): 722–723.
https://doi.org/10.1182/blood.V99.2.722
Published: 2002
Journal Articles

Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma

Inge Tinhofer, Ingrid Marschitz, Traudl Henn, Alexander Egle, Richard Greil
Journal: Blood
Blood (2000) 95 (2): 610–618.
https://doi.org/10.1182/blood.V95.2.610
Published: 2000
Journal Articles

Differential Sensitivity of CD4 + and CD8 + T Lymphocytes to the Killing Efficacy of Fas (Apo-1/CD95) Ligand + Tumor Cells in B Chronic Lymphocytic Leukemia

Inge Tinhofer, Ingrid Marschitz, Marion Kos, Traudl Henn, Alexander Egle, Andreas Villunger, Richard Greil
Journal: Blood
Blood (1998) 91 (11): 4273–4281.
https://doi.org/10.1182/blood.V91.11.4273
Published: 1998
Journal Articles

Constitutive Expression of Fas (Apo-1/CD95) Ligand on Multiple Myeloma Cells: A Potential Mechanism of Tumor-Induced Suppression of Immune Surveillance

Andreas Villunger, Alexander Egle, Ingrid Marschitz, Marion Kos, Günther Böck, Heinz Ludwig, Stephan Geley, Reinhard Kofler, Richard Greil
Journal: Blood
Blood (1997) 90 (1): 12–20.
https://doi.org/10.1182/blood.V90.1.12
Published: 1997